Why the study?
Does a single pre-induction intravenous dose of dexmedetomidine reduce anaesthetic requirements and improve peri-operative haemodynamic stability in patients undergoing minor orthopaedic and general surgery?
Does a single pre-induction intravenous dose of dexmedetomidine reduce anaesthetic requirements and improve peri-operative haemodynamic stability in patients undergoing minor orthopaedic and general surgery?
A single pre-induction dose of dexmedetomidine reduces intra-operative isoflurane requirements and improves peri-operative haemodynamic stability, though it increases the risk of hypotension and bradycardia.
Answers are grounded in this paper and cite their sources.
Supports reduced volatile use in minor surgery; confirms anaesthetic-sparing effect of pre-induction dexmedetomidine in this RCT.
In a double-blind, placebo-controlled study we investigated the effect of a single pre-induction intravenous dose of dexmedetomidine 2 micrograms.kg-1 on anaesthetic requirements and peri-operative haemodynamic stability in 50 patients undergoing minor orthopaedic and general surgery. Patients were anaesthetised with nitrous oxide/oxygen/fentanyl, supplemented if necessary with isoflurane. The mean (SD) intra-operative isoflurane concentration was lower in the dexmedetomidine-treated patients than controls (0.01 (0.03)% compared to 0.1 (0.1)%; p = 0.001) although six of the 25 treated patients required isoflurane at some stage. The haemodynamic response to tracheal intubation and extubation was reduced in the dexmedetomidine group as was intra-operative heart rate variability; postoperative analgesic and anti-emetic requirements and peri-operative serum catecholamine concentrations were lower in the dexmedetomidine group. Hypotension and bradycardia occurred more frequently after dexmedetomidine.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: